|
Pronunciation |
|
(DYE
kloe
neen) |
|
|
U.S. Brand
Names |
|
Dyclone®;
Sucrets®[OTC] |
|
|
Generic
Available |
|
No |
|
|
Synonyms |
|
Dyclonine Hydrochloride |
|
|
Pharmacological Index |
|
Local Anesthetic; Local Anesthetic, Oral |
|
|
Use |
|
Local anesthetic prior to laryngoscopy, bronchoscopy, or endotracheal
intubation; use topically for temporary relief of pain associated with oral
mucosa or anogenital lesions |
|
|
Pregnancy Risk
Factor |
|
C |
|
|
Contraindications |
|
Contraindicated in patients allergic to chlorobutanol (preservative used in
dyclonine) or dyclonine |
|
|
Warnings/Precautions |
|
Use with caution in patients with sepsis or traumatized mucosa in the area of
application to avoid rapid systemic absorption; may impair swallowing and
enhance the danger of aspiration; use with caution in patients with shock or
heart block; resuscitative equipment, oxygen, and resuscitative drugs should be
immediately available when dyclonine topical solution is administered to mucous
membranes; not for injection or ophthalmic use |
|
|
Adverse
Reactions |
|
<1%: Hypotension, bradycardia, respiratory arrest, cardiac arrest,
excitation, drowsiness, nervousness, dizziness, seizures, slight irritation and
stinging may occur when applied, blurred vision, allergic
reactions |
|
|
Overdosage/Toxicology |
|
Symptoms of overdose are primarily CNS (seizures, excitation) and
cardiovascular (hypotension, myocardial depression)
Treatment is supportive with fluids and pressors (particularly those that
stimulate the myocardium); diazepam 0.1 mg/kg can be used to control seizures
|
|
|
Drug
Interactions |
|
No data reported |
|
|
Stability |
|
Store in tight, light-resistant containers |
|
|
Mechanism of
Action |
|
Blocks impulses at peripheral nerve endings in skin and mucous membranes by
altering cell membrane permeability to ionic transfer |
|
|
Pharmacodynamics/Kinetics |
|
Onset of local anesthesia: 2-10 minutes
Duration: 30-60 minutes |
|
|
Usual Dosage |
|
Use the lowest dose needed to provide effective anesthesia
Mouth sores: 5-10 mL of 0.5% or 1% to oral mucosa (swab or swish and then
spit) 3-4 times/day as needed; maximum single dose: 200 mg (40 mL of 0.5%
solution or 20 mL of 1% solution)
Bronchoscopy: Use 2 mL of the 1% solution or 4 mL of the 0.5% solution
sprayed onto the larynx and trachea every 5 minutes until the reflex has been
abolished |
|
|
Dietary
Considerations |
|
Food should not be ingested for 60 minutes following application in the mouth
or throat area |
|
|
Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
No information available to require special precautions |
|
|
Dental Health:
Effects on Dental Treatment |
|
No effects or complications reported |
|
|
Patient
Information |
|
This medication is given to reduce sensation in the injected area. When used
in mouth or throat; do not eat or drink anything for at least 1 hour following
treatment. Take small sips of water at first to ensure that you can swallow
without difficulty. Your tongue and mouth may be numb - use caution to avoid
biting yourself. Immediately report swelling of face, lips, tongue; chest pain
or palpitations; increased restlessness, confusion, anxiety, or dizziness.
Pregnancy/breast-feeding precautions: Inform prescriber if you are or intend
to be pregnant. Consult prescriber if breast-feeding. |
|
|
Nursing
Implications |
|
Use the lowest dose needed to provide effective anesthesia; not for
injection; do not apply nasally or to the eye |
|
|
Dosage Forms |
|
Lozenges, as hydrochloride: 1.2 mg, 3 mg
Solution, topical, as hydrochloride: 0.5% (30 mL); 1% (30 mL)
|
|
|
References |
|
Carnel SB, Blakeslee DB, Oswald SG, et al,
"Treatment of Radiation- and Chemotherapy-Induced Stomatitis," Otolaryngol
Head Neck Surg, 1990, 102(4):326-30.
Gargiulo AV, Burns GM, and Huck CP,
"Dyclonine Hydrochloride - A Topical Agent for Managing Pain," Ill Dent
J, 1992, 61(4):303-4.
Nelson LA, "Nonprescription Drug Screening. Dyclonine Hydrochloride," Am
Pharm, 1987, NS27(9):27-9. |
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
|